drugset / Trial / NCT00221442

Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity

NCT00221442

RandomizedSingle-groupTriple-blindTreatment

Summary

The specific aim of this study is to examine the efficacy and safety of zonisamide compared with placebo in outpatients with binge eating disorder associated with obesity.

Timeline

Start
2005-08
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zonisamide Other / unclassified

Indications